Related Experiment Video
Updated: May 26, 2025

Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests
Published on: September 6, 2024
"Trafficking Disorders: Phenotypical Similarities and Differences With Other IMDs".
Ángeles García-Cazorla1, Eva Morava2, Jean-Marie Saudubray3
1Neurometabolic Unit and Synaptic Metabolism Laboratory. Department of Neurology, Hospital Sant Joan de Déu, IRSJD, CIBERER and MetabERN, Barcelona, Spain.
Cell trafficking disorders (CTD) are genetic defects impacting complex molecules, often misdiagnosed. Recognizing CTD as a distinct group is crucial for accurate diagnosis and treatment of these multisystem inherited metabolic diseases.
Area of Science:
- Biochemistry
- Genetics
- Immunology
Background:
- Cell trafficking disorders (CTD) represent the largest category of inborn errors of metabolism (IEM), stemming from genetic defects in complex molecules.
- They are often overlooked as isolated rare diseases rather than a cohesive group, particularly by non-metabolic specialists.
- Complex lipid metabolism is intrinsically linked to cell trafficking and organelle interactions at membrane contact sites.
Purpose of the Study:
- To highlight cell trafficking disorders (CTD) as a significant and under-recognized category of inborn errors of metabolism (IEM).
- To emphasize the characteristic multisystemic manifestations of CTD, including neurological and immune system involvement.
- To discuss the diagnostic challenges and limited biomarkers associated with CTD.
Main Methods:
- Review of genetic defects affecting complex molecules and cell trafficking pathways.
- Analysis of clinical presentations, including multisystem manifestations and neurological involvement.
- Comparison of CTD with other inborn errors of metabolism (IEM) such as mitochondrial, peroxisomal, lysosomal disorders, CDG, and autophagy disorders.
Main Results:
- CTD involve mutations in over 370 genes, impacting complex lipid metabolism and organelle interactions.
- Clinical features are diverse, affecting multiple organ systems and mimicking other IEMs; neurological and immune system involvement are particularly characteristic.
- Most CTD are progressive, may present with metabolic crises, and are typically diagnosed via exome sequencing, with few available biomarkers.
Conclusions:
- Cell trafficking disorders (CTD) constitute a major, yet underappreciated, category of inborn errors of metabolism (IEM) requiring broader recognition.
- The multisystemic nature and unique immune system involvement in CTD necessitate specialized diagnostic approaches.
- Further research into biomarkers and diagnostic strategies is essential for improved management of CTD.
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pedigree Analysis
Sex-linked Disorders
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...

